BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
65.48
+1.60 (2.50%)
At close: Jun 3, 2026, 4:00 PM EDT
62.63
-2.86 (-4.36%)
After-hours: Jun 3, 2026, 5:28 PM EDT
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $104 | Buy | Initiates | $104 | +58.83% | Jun 3, 2026 |
| Citi | Citi | Hold Maintains $82 | Hold | Maintains | $82 | +25.23% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $110 | Buy | Reiterates | $110 | +67.99% | May 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $94 → $98 | Buy | Maintains | $94 → $98 | +49.66% | May 27, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
| Raymond James | Raymond James | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $96 → $101 | Buy | Reiterates | $96 → $101 | +54.25% | May 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $100 | Buy | Maintains | $100 | +52.72% | May 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.